LAVA Therapeutics Management
Management criteria checks 3/4
LAVA Therapeutics' CEO is Steve Hurly, appointed in Jun 2019, has a tenure of 5.58 years. directly owns 0.019% of the company’s shares, worth $5.40K. The average tenure of the management team and the board of directors is 3.5 years and 3.9 years respectively.
Key information
Steve Hurly
Chief executive officer
US$814.4k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.6yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3.5yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Revenues Working Against LAVA Therapeutics N.V.'s (NASDAQ:LVTX) Share Price Following 25% Dive
Jun 02
LAVA Therapeutics (NASDAQ:LVTX) Has Debt But No Earnings; Should You Worry?
Mar 01LAVA Therapeutics: Assessing A Promising Innovator
Oct 18LAVA Therapeutics GAAP EPS of -$0.31 beats by $0.30, revenue of $0.47M beats by $0.11M
Sep 13CEO
Steve Hurly (56 yo)
5.6yrs
Tenure
US$814,399
Compensation
Mr. Stephen Allen Hurly, also known as Steve, MSc, MBA, serves as Chief Executive Officer, President and Executive Director at Lava Therapeutics N.V. since June 2019. Mr. Hurly was Chief Executive Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 5.6yrs | US$814.40k | 0.019% $ 5.4k | |
| Chief Financial Officer | 2.2yrs | no data | 0.25% $ 70.2k | |
| Chief Scientific Officer | 8yrs | no data | 0.29% $ 83.5k | |
| General Counsel & Corporate Secretary | 3.5yrs | no data | 0.034% $ 9.6k | |
| VP & Head of Human Resources | 3.2yrs | no data | no data | |
| Chief Development Officer | 7.5yrs | no data | 0.024% $ 6.9k | |
| Chief Medical Officer | 1.9yrs | no data | 0% $ 0 |
3.5yrs
Average Tenure
57.5yo
Average Age
Experienced Management: LVTX's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 5.6yrs | US$814.40k | 0.019% $ 5.4k | |
| Independent Non-Executive Director | 2.6yrs | US$52.50k | 0% $ 0 | |
| Independent Non-Executive Director | 3.8yrs | US$55.00k | 0.038% $ 10.8k | |
| Member of Advisory Board | 5yrs | no data | no data | |
| Non-Executive Director | 2.6yrs | US$47.00k | 0% $ 0 | |
| Non-Executive Chairman | 3.9yrs | US$82.63k | 0.11% $ 32.4k | |
| Non-Executive Director | 1.8yrs | US$37.85k | 0% $ 0 | |
| Chairman of Advisory Board | 6.8yrs | no data | no data | |
| Member of Advisory Board | 5yrs | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data |
3.9yrs
Average Tenure
61yo
Average Age
Experienced Board: LVTX's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 03:06 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LAVA Therapeutics N.V. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yu He | H.C. Wainwright & Co. |
| Christopher Howerton | Jefferies LLC |
| Roger Song | Jefferies LLC |